Heart Failure Clinical Trials
CORVIA: REDUCE-LAP-HF
View CORVIA: REDUCE-LAP-HF information
Evaluates the clinical efficacy and safety of the IASD System II in symptomatic heart failure patients with an LV ejection fraction ≥40%, and elevated left sided filling pressures despite standard Guideline Directed Medical Therapy (GDMT).
Primary Investigator: Will be announced
Subinvestigator: Nunzio Gaglianello, MD, Nicole Lohr, MD, PhD.
Status: Currently enrolling
Sub Category: Advanced Heart Failure
Subinvestigator: Nunzio Gaglianello, MD, Nicole Lohr, MD, PhD.
Status: Currently enrolling
Sub Category: Advanced Heart Failure
Meet Our Team

Nunzio A. Gaglianello, MD
Associate Professor

Nicole Lohr, MD, PhD, FACC
Associate Professor, Medical Director Cardiovascular Clinical Trials
Cardiovascular Clinical Trials
The Cardiovascular Research Service is currently conducting drug and/or device trials in the cardiac subspecialties listed. However, this does not limit what we may be working on tomorrow.
Please contact the Cardiovascular Trials program by calling (414) 955-7021 or at DOMCVClinTriStaff@mcw.edu.